Latest News

The Dow shed 971 points on Monday and the Nasdaq gapped 2.6% lower, with both indexes marking fourth-straight losses.

Higher bond yields failed to attract any interest, and the increased selling today was met with even more vigorous buying in gold.

Clinical research company Medpace Holdings (NASDAQ:MEDP) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $558.6 million. The company’s full-year revenue guidance of $2.19 billion at the midpoint came in 1.9% above analysts’ estimates. Its GAAP profit of $3.67 per share was 20.8% above analysts’ consensus estimates.

We're truly dealing with equity market destruction of epic proportions since the President re-took office.

Metal coating and infrastructure solutions provider AZZ (NYSE:AZZ) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 4% year on year to $351.9 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.68 billion at the midpoint. Its non-GAAP profit of $0.98 per share was in line with analysts’ consensus estimates.

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Monday. Uncover the top gainers and losers in today's session for valuable insights.

Medpace Holdings reports first-quarter financial results after the market close on Monday. Here's a look at the key metrics from the quarter.

While all eyes are on the declining equity markets, far more important developments are taking place in the debt and currency markets.

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Tariff policies can likely cause a big economic hit in the near term and stocks are likely to fall further, says this expert. Here's why.